Eye Health News and Research

Latest Eye Health News and Research

NEI awards Case Western Reserve $1.57M for bacterial keratitis research

Researchers at Case Western Reserve University School of Medicine have been awarded a $1.57 million renewal grant from the National Eye Institute (NEI) of the National Institutes of Health to continue their study of corneal infections, specifically, bacterial keratitis, associated with contact lens wear. The grant will extend the work initiated last year with the receipt of a $2.4 million, five-year grant from the NEI.

8 Oct 2009

Unilens Vision launches disposable C-VUE Advanced Toric Multifocal lens

Unilens Vision Inc., which develops, licenses, manufactures, distributes and markets specialty contact lenses, today announced the launch of the all new monthly C-VUE Advanced® Toric Multifocal.

8 Oct 2009

World Sight Day to focus global attention on blindness and vision impairment

World Sight Day, celebrated on October 8th, is an annual day of awareness to focus global attention on blindness and vision impairment as a major public health issue. World Sight Day is coordinated by the International Agency for the Prevention of Blindness (IAPB) under the global initiative of VISION 2020. This year, the theme for World Sight Day is Gender and Eye Health.

8 Oct 2009

Swine Flu prevention tips from California dentists

In keeping with the global effort to limit the spread of the Swine Flu, the California Dental Hygienists’ Association (CDHA) issued a list today of simple ways patients and oral health professionals can prevent catching and spreading the disease.

8 Oct 2009

New England Donor Registry launched by Donate Life

Donate Life New England, a joint project of two federally designated organ procurement organizations that serve New England, today announced that individuals can now – for the first time – enroll online in the New England Donor Registry at www.donatelifenewengland.org.

8 Oct 2009

Roche and Genentech obtain license to use SurModics’ drug delivery system

SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry, announced today that it has signed a License and Development Agreement with Roche and Genentech, Inc., a wholly-owned member of the Roche Group.

7 Oct 2009

IP Advocate collaborates with Marion Kauffman Foundation on education and policy initiatives

Sharing a mutual goal of helping researchers turn their discoveries into products that help people and stimulate the economy, IP Advocate (http://www.IPAdvocate.org) founder and noted scientist Dr. Renee Kaswan is collaborating with the Ewing Marion Kauffman Foundation (http://www.kauffman.org) on a range of education and policy initiatives.

7 Oct 2009

Views on primary source of healthcare reform funding differ between payers and physicians

Responding to President Obama's claim that funding for proposed US healthcare reforms exists within the current system, payers and physicians have different views on where the savings will be found to support the new initiatives.

7 Oct 2009

Scientific community must fight misconceptions about experiments using animals: Researchers

In a recent commentary, We must face the threats, in the Journal of Neuroscience, researchers Dario Ringach and David Jentsch spoke out against animal rights extremism. They urged the scientific community to stand together and fight misconceptions about experiments using animals. That their plea has been heard is clear from the unanimously positive response it received on the Faculty of 1000 Biology website.

7 Oct 2009

Research to explore diagnosis and treatment of rare diseases

The National Institutes of Health announced today a second phase of the Rare Diseases Clinical Research Network (RDCRN) including funds for 19 research consortia.

7 Oct 2009

Biovail provides update on its Phase III program with pimavanserin for Parkinson’s disease psychosis

Biovail Corporation today provided an update on its Phase III program with pimavanserin for Parkinson’s disease psychosis (PDP), which is being pursued in collaboration with ACADIA Pharmaceuticals Inc. Following the announcement on September 1st of disappointing top-line results from the first Phase III PDP trial, Biovail and ACADIA remain committed to the successful development of pimavanserin and have established a development strategy that they believe will strengthen the PDP program.

7 Oct 2009

Early Phase II clinical trial for RK-023 to treat androgenetic alopecia

R-Tech Ueno, Ltd. has started early Phase II clinical trial for RK-023, a physiologically active fatty acid derivative developed by the company -- a new compound targeted as a treatment for androgenetic alopecia (male pattern baldness).

7 Oct 2009

University of Leicester's event to cope with challenging and distressing situations

The University of Leicester will go on 'Red Alert' on Saturday 10th October, when fire officers, paramedics and international experts in triage, pandemics and major trauma converge on the campus for the staging of a chemical/biological/radioactive incident.

7 Oct 2009

Update from ACADIA Pharmaceuticals regarding its Phase III program with pimavanserin

ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today provided an update on its Phase III program with pimavanserin for Parkinson’s disease psychosis (PDP), which is being pursued in collaboration with Biovail Laboratories International SRL (“Biovail”), a subsidiary of Biovail Corporation.

6 Oct 2009

Promising alternative to use of live animals for drug testing

International Stem Cell Corporation, the first company to perfect a method of creating human “parthenogenetic” stem cells from unfertilized eggs, announces positive results of its collaboration with Absorption Systems to study ISCO’s stem-cell-derived human corneal tissue as an alternative to live animals for drug testing.

6 Oct 2009

AAOS to participate in "Get Connected" electronic prescribing program

The American Academy of Orthopaedic Surgeons (AAOS) today announced their participation in "Get Connected," a program designed to help more of the nation's physicians and other prescribers use electronic prescribing.

6 Oct 2009

Government of Alberta reimburses first medication to improve vision and restore quality of life

Alberta residents with neovascular (wet) age-related macular degeneration (AMD), the leading cause of vision loss over the age of 50, have received a dose of good news with the decision by Alberta Health and Wellness to reimburse the innovative treatment Lucentis* (ranibizumab) on the Alberta Blue Cross insurance plan.

6 Oct 2009

Researchers identify novel circulation within human eye that provides new insight into glaucoma

Researchers at the University of Toronto, St. Michael's Hospital and Sunnybrook Health Sciences Centre have discovered a previously unidentified form of circulation within the human eye which may provide important new insights into glaucoma, a leading cause of blindness.

6 Oct 2009

Center for Health Value Innovation aligns with ACOEM and IBI to launch HPM Clinics

The Center for Health Value Innovation (www.vbhealth.org), the nation’s premier information exchange for value-based design, today announced an alignment with the American College of Occupational and Environmental Medicine and the Integrated Benefits Institute, creating a powerful triumvirate to better articulate the value of health and productivity management (HPM).

6 Oct 2009

ThromboGenics presents Phase IIa microplasmin intravitreal injection trial results at the ASRS conference

ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative medicines for eye disease, vascular disease and cancer, today announces results of a Phase IIa trial evaluating microplasmin intravitreal injection for the treatment of Diabetic Macular Edema (MIVI II DME).

6 Oct 2009

Eye Health News and Research

Latest Eye Health News and Research

NEI awards Case Western Reserve $1.57M for bacterial keratitis research

Unilens Vision launches disposable C-VUE Advanced Toric Multifocal lens

World Sight Day to focus global attention on blindness and vision impairment

Swine Flu prevention tips from California dentists

New England Donor Registry launched by Donate Life

Roche and Genentech obtain license to use SurModics’ drug delivery system

IP Advocate collaborates with Marion Kauffman Foundation on education and policy initiatives

Views on primary source of healthcare reform funding differ between payers and physicians

Scientific community must fight misconceptions about experiments using animals: Researchers

Research to explore diagnosis and treatment of rare diseases

Biovail provides update on its Phase III program with pimavanserin for Parkinson’s disease psychosis

Early Phase II clinical trial for RK-023 to treat androgenetic alopecia

University of Leicester's event to cope with challenging and distressing situations

Update from ACADIA Pharmaceuticals regarding its Phase III program with pimavanserin

Promising alternative to use of live animals for drug testing

AAOS to participate in "Get Connected" electronic prescribing program

Government of Alberta reimburses first medication to improve vision and restore quality of life

Researchers identify novel circulation within human eye that provides new insight into glaucoma

Center for Health Value Innovation aligns with ACOEM and IBI to launch HPM Clinics

ThromboGenics presents Phase IIa microplasmin intravitreal injection trial results at the ASRS conference

Genetics & Genomics - Second Edition eBook

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Eye Health News and Research

Latest Eye Health News and Research

Genetics & Genomics - Second Edition eBook

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in